Turning robust data into real-world impact
You can’t make world-changing impact without the right insights. Built on a foundation of rigorous research, collaboration and real-world experience, Impact Global Health’s insights make data actionable and motivating for the funders, policy makers, advocates and product developers.
Hubs
Explore a series of carefully-curated resource hubs for some of the world's most challenging and impactful health topics.
EXPLORE OUR
Women's Health Hub
Looking at the gender bias in R&D, this resource hub provides a suite of data, insights and tools to accelerate progress in women’s health.
EXPLORE OUR
Impact of Global Health R&D Hub
A milestone analysis of the health and economic impact of the last two decades of investment in global health R&D.
Browse by disease and condition
This quick reference guide gives you a snapshot analysis of the R&D needs and the state of innovation to tackle each disease or condition we cover. It's a handy quick overview of what's needed to impact global health in these areas:
- Neglected diseases
- Emerging infectious diseases
- Sexual & reproductive health issues
Browse the report library
Our reports deliver critical insights using the evidence collected through G-FINDER and over two decades of independent analysis.
30 min read
The ripple effect: how global health R&D delivers for everyone
This report shows how investments in global health R&D deliver significant health and economic progress for HICs as well as LMICs. We examine how much government funding from HICs has gone to global health R&D, how much of it stays within HICs, and the macroeconomic and scientific gains it leads to. We spotlight case studies that show how innovations developed for LMICs have gone on to help HIC populations, proving that smart, sustained investment pays dividends globally and locally.
20 min read
Flying Blind
This report provides a critical and timely landscape analysis of global R&D for endometriosis, polycystic ovary syndrome (PCOS) and uterine fibroids. In it, we evaluate and contextualise current investment, and review and analyse the pipeline of biomedical products developed and used to diagnose and treat them.
20 min read
Irresistible: developing new solutions for antimicrobial resistant STIs
In this report, we consider the future global response to three AMR-risk STIs: gonorrhoea, trichomoniasis and Mycoplasma genitalium. We analyse the funding that has been provided to research and develop new treatments, vaccines and diagnostics, and the resulting product pipeline for each of the three infections and their disease-causing pathogens.
You may also be interested in
Tracking global health investments: discover G-FINDER's impact
We created G-FINDER to track R&D funding for new products and technologies that impact health challenges for disadvantaged populations. Explore the data and see how you can impact global health.
The need for impact: See how the investment in global recipients and products creates change.
How impact is funded: Explore the funding landscape that is having impact.
View G-FINDER dataInfectious Disease R&D Tracker
A comprehensive list of approved health products and technologies, as well as candidates in the development pipeline for global health priority issues.
Maternal Health Pipeline
Database profiling medicines, diagnostics, and devices for seven significant pregnancy-related conditions.
Snakebite Envenoming Medicines Database
Database of all snakebite envenoming medicines with direct action on toxins, approved or in the pipeline since 2015.